miR-28-based combination therapy impairs aggressive B Cell Lymphoma growth by rewiring DNA replication

ID: 2311

Autores: G de Yébenes, Virginia (0); G de Yéebenes, Virginia (1); Fuertes, Teresa (2); Álvarez-Corrales, Emigdio (1); Gómez-Escolar, Carmen (2); Ubieto-Capella, Patricia (3); Serrano-Navarro, Álvaro (2); de Molina, Antonio (2); Méndez, Juan (3); R. Ramiro, Almudena (2)

Temática: New frontiers in treatment/Precision medicine